Skip to content

VM DERMATO

Active
Private limited companyfounded 2020active for 6 yearsWeststraat 2, 8647 Lo-Reninge, BelgiumKBO/BCE: BE 0750.595.403
Summary

VM DERMATO has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €123,991 and a net result of €47,014. Equity is growing by about 21% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).

History

On 13 July 2020, VM DERMATO was incorporated as a private limited company.1 Total assets went from €23,628 in 2020 to €228,113 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2020 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
31-08
NBB filing Annual accounts filed
financial year 2025 · micro format · 31 days late
2025
31-12
Financial Highest result from 2020 to 2025net €47,014 ▲20.9%
Operating result €60,040, net result €47,014, both a record.
30-08
NBB filing Annual accounts filed
financial year 2024 · micro format · 30 days late
2024
29-08
NBB filing Annual accounts filed
financial year 2023 · micro format · 29 days late
2023
31-12
Financial Equity above €100,000equity €121,084 ▲36.8%
A profit in every financial year since 2020 builds equity to €121,084.
22-12
NBB filing Annual accounts filed
financial year 2022 · micro format · 144 days late
2022
31-12
Financial Liquidity more than doubledcurrent ratio 25.10
Current ratio from 9.96 to 25.10; short-term debt falls from €6,205 to €3,673.
30-09
NBB filing Annual accounts filed
financial year 2021 · micro format · 61 days late
2021
21-09
NBB filing Annual accounts filed
financial year 2020 · micro format · 52 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.